Advertisement

January 22, 2022

Penile Complications After Urethroplasty: Who Cares?

  • Silke Riechardt
Published online: January 22, 2022

January 21, 2022

Proficiency-based Progression Training: A Scientific Approach to Learning Surgical Skills

  • Anthony G. Gallagher,
  • Ruben De Groote,
  • Marco Paciotti,
  • Alexandre Mottrie
Published online: January 21, 2022

January 19, 2022

Quality and Quantity: Evaluating Tumor Biology Alongside Novel Imaging on Diagnosis of Metastatic Hormone-sensitive Prostate Cancer

  • Vanessa Di Lalla,
  • Michael J. Kucharczyk,
  • Alexander W. Wyatt,
  • ...
  • Jonathan So,
  • Fred Saad,
  • Tamim Niazi
Published online: January 19, 2022

January 17, 2022

Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy

  • Qing Cheng,
  • William Butler,
  • Yinglu Zhou,
  • ...
  • Shannon J. McCall,
  • Brant A. Inman,
  • Jiaoti Huang
Published online: January 17, 2022

January 14, 2022

January 13, 2022

A Point-of-Care Resource to Improve Care of Patients with Adrenal Mass: www.AdrenalMass.org

  • Marshall Strother,
  • Julie Hallanger Johnson,
  • Alexander Kutikov
Published online: January 13, 2022

January 11, 2022

A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry

  • Burcu F. Darst,
  • Raymond Hughley,
  • Aaron Pfennig,
  • ...
  • Timothy R. Rebbeck,
  • David V. Conti,
  • Christopher A. Haiman
Published online: January 11, 2022
Open Access

Re: Fibroblast Growth Factor Receptor 1 Drives the Metastatic Progression of Prostate Cancer

  • Rolf I. Skotheim,
  • Ulrika Axcrona,
  • Karol Axcrona
Published online: January 11, 2022

Re: Molecular Features of Exceptional Response to Neoadjuvant Anti-androgen Therapy in High-risk Localized Prostate Cancer

  • Wout Devlies,
  • Gaëtan Devos,
  • Henri Decloedt,
  • Bram Vansevenant,
  • Frank Claessens,
  • Steven Joniau
Published online: January 11, 2022

Magnetic Resonance Imaging–guided Adaptive Radiotherapy for Urological Cancers: What Urologists Should Know

  • Linda G.W. Kerkmeijer,
  • Amar U. Kishan,
  • Alison C. Tree
Published online: January 11, 2022

January 10, 2022

January 8, 2022

January 7, 2022

January 6, 2022

January 4, 2022

January 3, 2022

Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis

  • Thi Oanh Bui,
  • Van Tu Dao,
  • Van Tai Nguyen,
  • Jean-Paul Feugeas,
  • Frédéric Pamoukdjian,
  • Guilhem Bousquet
Published online: January 03, 2022

December 31, 2021

Defining the Impact of Family History on Detection of High-grade Prostate Cancer in a Large Multi-institutional Cohort

  • Matthew B. Clements,
  • Emily A. Vertosick,
  • Lourdes Guerrios-Rivera,
  • ...
  • Cedric Poyet,
  • Donna P. Ankerst,
  • Andrew J. Vickers
Published online: December 31, 2021

Molecular Genetic Determinants of Shorter Time on Active Surveillance in a Prospective Phase 2 Clinical Trial in Metastatic Renal Cell Carcinoma

  • Oscar Reig Torras,
  • Akhilesh Mishra,
  • Alana Christie,
  • ...
  • Payal Kapur,
  • James Brugarolas,
  • Brian Rini
Published online: December 31, 2021

December 23, 2021

Stereotactic Radiotherapy and Short-course Pembrolizumab for Oligometastatic Renal Cell Carcinoma—The RAPPORT Trial

  • Shankar Siva,
  • Mathias Bressel,
  • Simon T. Wood,
  • ...
  • Declan G. Murphy,
  • Nathan Lawrentschuk,
  • David Pryor
Published online: December 23, 2021

International Bladder Cancer Group Consensus Statement on Clinical Trial Design for Patients with Bacillus Calmette-Guérin–exposed High-risk Non–muscle-invasive Bladder Cancer

  • Mathieu Roumiguié,
  • Ashish M. Kamat,
  • Trinity J. Bivalacqua,
  • ...
  • Richard Sylvester,
  • J. Alfred Witjes,
  • Peter C. Black
Published online: December 23, 2021

December 22, 2021

Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer

  • Veerle H. Groen,
  • Karin Haustermans,
  • Floris J. Pos,
  • ...
  • Jochem van der Voort van Zijp,
  • Linda G.W. Kerkmeijer,
  • Uulke A. van der Heide
Published online: December 22, 2021

Genomic Features of Muscle-invasive Bladder Cancer Arising After Prostate Radiotherapy

  • Matthew Mossanen,
  • Filipe L.F. Carvalho,
  • Vinayak Muralidhar,
  • ...
  • Adam S. Kibel,
  • Eliezer M. Van Allen,
  • Kent W. Mouw
Published online: December 22, 2021

December 20, 2021

December 18, 2021

December 15, 2021

2021 Updated European Association of Urology Guidelines on the Use of Adjuvant Pembrolizumab for Renal Cell Carcinoma

  • Jens Bedke,
  • Laurence Albiges,
  • Umberto Capitanio,
  • ...
  • Rana Tahbaz,
  • Thomas Powles,
  • Axel Bex
Published online: December 15, 2021

December 14, 2021

A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data

  • Karin Welén,
  • Ebba Rosendal,
  • Magnus Gisslén,
  • ...
  • Anne-Marie Fors Connolly,
  • Anna K. Överby,
  • Andreas Josefsson
Published online: December 14, 2021
Open Access

December 13, 2021

Deep Prostate-specific Antigen Response following Addition of Apalutamide to Ongoing Androgen Deprivation Therapy and Long-term Clinical Benefit in SPARTAN

  • Fred Saad,
  • Eric J. Small,
  • Felix Y. Feng,
  • ...
  • Suneel D. Mundle,
  • Simon Chowdhury,
  • Matthew R. Smith
Published online: December 13, 2021
Open Access

December 9, 2021

Re: Adjuvant Pembrolizumab After Nephrectomy in Renal-cell Carcinoma

  • Diana E. Magee,
  • Alexander Kutikov
Published online: December 09, 2021

Re: NCCN Prostate Cancer Guidelines Version 1.2022 – September 10, 2021

  • Jeremy Grummet,
  • Scott Eggener
Published online: December 09, 2021

December 8, 2021

December 7, 2021

Advertisement